Product Program year 2020 Source: CMS Open Payments

HydroPearl

Device Vascular Embolization

Open in the dashboard

General payments

$48,357

657 payments

Research payments

$91,404

5 payments

Through program year 2020, $48,357 in general payments and $91,404 in research payments were reported against HydroPearl (Vascular Embolization).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $20,969 236
2020 Research $91,404 5
2019 General $27,388 421

Breakdown

Who paid General payments · program years 2019–2020
  1. Terumo Medical Corporation $48,357 657 payments
Top recipients General payments · program year 2020
  1. Sandeep Bagla Vascular & Interventional Radiology · Falls Church, VA $8,205 39% · 4 payments
  2. Theresa Caridi Vascular & Interventional Radiology · Washington, DC $525 3% · 1 payment
  3. Ari Isaacson Vascular & Interventional Radiology · Chapel Hill, NC $350 2% · 1 payment
  4. Sameer Mittal Urology · Philadelphia, PA $311 1% · 2 payments
  5. Anup Singh Vascular & Interventional Radiology · San Jose, CA $290 1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular & Interventional Radiology Radiology $14,330 69% · 86 practitioners
  2. Diagnostic Radiology Radiology $3,658 18% · 56 practitioners
  3. Urology $706 3% · 4 practitioners
  4. Obstetrics & Gynecology $675 3% · 11 practitioners
  5. Vascular Surgery Surgery $219 1% · 4 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Maryland $8,862 42% · 4 recipients
  2. California $3,215 15% · 35 recipients
  3. Texas $1,191 6% · 14 recipients
  4. Louisiana $1,185 6% · 9 recipients
  5. Arizona $773 4% · 14 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

657 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record